Applied Genetic Technologies Corporation

The Applied Genetic Technologies Corporation is a publicly traded (NASDAQ:AGTC)[1] biotechnology company that is part of the NASDAQ Biotechnology Index. It was founded in 1999 and has it headquarters in Alachua, Florida.[2] The company focuses on ophthalmologic genetic diseases. The company's technologies have the ability to cure debilitating genetic diseases which include achromatopsia, X-linked retinoschisis,[3][4] X-linked retinitis pigmentosa,[5][6][7] and age-related macular degeneration.[8][9][10][11] The company has six products in various stages of development.[12]

References

  1. ↑ "Applied Genetic Technologies Corporation (AGTC)". NASDAQ.com. Retrieved 4 January 2016.
  2. ↑ "Company Overview of Applied Genetic Technologies Corporation". Bloomberg. Retrieved November 15, 2016.
  3. ↑ Chen, Angela. "Biogen to Pay Applied Genetic $124 Million to Develop Eye-Disease Treatments". Wall Street Journal. Retrieved 4 January 2016.
  4. ↑ "AGTC Announces Data Evaluating the Natural History of Patients With X-Linked Retinoschisis at the 48th Annual Retina Society Meeting". Yahoo Finance. Retrieved 4 January 2016.
  5. ↑ "New therapy may treat form of blindness". The Independent Florida Alligator. Retrieved 4 January 2016.
  6. ↑ "Biogen enters eye-treatment arena with AGTC deal". Yahoo Finance.
  7. ↑ "Biogen enters eye-treatment arena with AGTC deal". Reuters. 2 July 2015. Retrieved 4 January 2016.
  8. ↑ "http://www.sciencedaily.com/releases/2015/12/151221111433.htm". www.sciencedaily.com. Retrieved 4 January 2016. External link in |title= (help)
  9. ↑ "Study reveals new genetic clues to macular degeneration". www.yourconroenews.com. Retrieved 4 January 2016.
  10. ↑ Ballie, Katherine. "Penn-Michigan State Team Develops Novel Gene Therapy for Achromatopsia". www.upenn.edu. Retrieved 4 January 2016.
  11. ↑ Whiteman, Honor. "Cure for rare form of color blindness steps closer with novel gene insight". Medical News Today. Retrieved 4 January 2016.
  12. ↑ "Finding Cures for Visual Disorders l Products". www.agtc.com. Retrieved 4 January 2016.

External links


This article is issued from Wikipedia - version of the 11/16/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.